ARCHIVES

OSI “Front Line Office” In Probes Of Scientific Misconduct, Kimes Tells NCAB

This article is from The Cancer Letter archive.

Vol. 15 No. 39 | October 13, 1989

Download PDF Visit The Full Archive

Related Articles

Hood’s ISB Gets $5 Million From Merck, Hires Scientists.

September 1, 2000

Clinical Trials: Breast Cancer Prevention Trial requires Fewer Participants, NCI Says

September 6, 1996

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Also R01 payline likely to fall below 20th percentile in FY04.

September 26, 2003

Children, Parents Differ In Decisionmaking On Cancer Treatment, Survivor Study Finds

July 29, 2005